Phase 2/3 trial of structurally distinct prodrug fosgonimeton (Athira ATH-1017) missed primary endpoint in 2023 Product Specifications Format: capsules Strength: 10 mg per capsule Count: 30 capsules per bottle Purity: 98% (HPLC verified) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
Its because of this that Mind Medicine Australia deputy chair and executive director Tania de Jong believes combatting mental illness is more important than ever
Studying the function of the candidate genes inside these QTLs would connect them to the development of specific CIs
Acute encephalitis showed elevated kynurenine, quinolinic acid, and anthranilic acid but decreased tryptophan, 3-hydroxyanthranilic acid and kynurenic acid 56
Treatment response prediction : personalizing drug regimens based on patient profiles (Burchill et al., 2024